Monopar Therapeutics (MNPR) Stock Chart & Stock Price History $39.76 -3.97 (-9.08%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$42.36 +2.60 (+6.53%) As of 08:25 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Monopar Therapeutics Stock Price Performance The Monopar Therapeutics (MNPR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 976.05%, with a year-to-date return of 80.73%. In the past month, the stock has increased 16.19%, reflecting recent market activity. As of the latest close, Monopar Therapeutics traded at $39.76 with a market cap of $243.33 million and volume of 85,566 shares. Five years ago, the stock traded at a split-adjusted price of $37.95, representing a 4.77% increase over that period. At the time, it had a market cap of $82.91 million and a volume of 1,820 shares. Receive MNPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+7.84%1 Month Performance+16.19%3 Month Performance+4.58%Year-To-Date Performance+80.73%1 Year Performance+976.05%5 Year Performance+4.77% MNPR Stock Chart for Wednesday, July, 16, 2025 MNPR Chart by TradingView Monopar Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$43.73$39.76-9.08%$45.00$39.6285,566 shs$243.33 million07/14/2025$36.87$43.73+18.61%$45.50$37.19124,760 shs$267.63 million07/11/2025$38.26$36.87-3.63%$38.25$35.5840,442 shs$225.64 million07/10/2025$40.44$38.26-5.39%$42.00$38.2335,147 shs$233.96 million07/09/2025$38.37$40.44+5.39%$40.47$37.1749,522 shs$247.49 million07/08/2025$37.20$38.37+3.15%$39.62$37.0062,086 shs$234.82 million07/07/2025$35.87$37.20+3.71%$37.78$35.3749,658 shs$227.66 million07/04/2025$35.87$35.87$36.25$34.9124,007 shs$219.52 million07/03/2025$35.16$35.87+2.02%$36.25$34.9124,007 shs$219.52 million07/02/2025$33.56$35.16+4.77%$36.11$33.5460,928 shs$215.00 million Get the Latest News and Ratings for MNPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$35.78$33.56-6.20%$36.20$33.0034,955 shs$205.39 million06/30/2025$33.60$35.78+6.49%$35.84$32.6854,162 shs$218.97 million06/27/2025$35.01$33.60-4.03%$35.00$31.84567,062 shs$205.63 million06/26/2025$31.92$35.01+9.68%$35.59$32.0024,388 shs$214.26 million06/25/2025$33.30$31.92-4.14%$33.31$31.1714,678 shs$195.35 million06/24/2025$31.83$33.30+4.62%$33.50$32.1437,236 shs$203.80 million06/23/2025$32.86$31.83-3.13%$33.75$31.8345,435 shs$194.64 million06/20/2025$33.00$32.86-0.42%$33.84$32.5421,168 shs$201.10 million06/19/2025$33.00$33.00$34.40$32.9515,170 shs$201.96 million06/18/2025$34.10$33.00-3.23%$34.40$32.9515,170 shs$201.80 million06/17/2025$34.22$34.10-0.35%$35.01$33.956,861 shs$208.52 million06/16/2025$33.52$34.22+2.09%$35.00$33.8113,341 shs$209.26 million Related Companies Avadel Pharmaceuticals Stock Price Chart Cogent Biosciences Stock Price Chart Oculis Stock Price Chart Chimerix Stock Price Chart Avid Bioservices Stock Price Chart uniQure Stock Price Chart CorMedix Stock Price Chart Cronos Group Stock Price Chart GH Research Stock Price Chart Syndax Pharmaceuticals Stock Price Chart Receive MNPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MNPR) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
